[1]
“GUSELKUMAB AS A NEW BIOLOGIC OPTION FOR THE MANAGEMENT OF ULCERATIVE COLITIS: A NARRATIVE REVIEW”, IJITSS, vol. 3, no. 4(48), Dec. 2025, doi: 10.31435/ijitss.4(48).2025.4702.